Citation: S. Kenney et al., GENE-THERAPY STRATEGIES FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOMAS - COMPARISON OF 2 DIFFERENT EPSTEIN-BARR VIRUS-BASED VECTORS, Human gene therapy, 9(8), 1998, pp. 1131-1141
Authors:
ZHANG Q
HOLLEYGUTHRIE E
GE JQ
DORSKY D
KENNEY S
Citation: Q. Zhang et al., THE EPSTEIN-BARR-VIRUS (EBV) DNA-POLYMERASE ACCESSORY PROTEIN, BMRF1,ACTIVATES THE ESSENTIAL DOWNSTREAM COMPONENT OF THE EBV ORILYT, Virology, 230(1), 1997, pp. 22-34
Authors:
ROGERS RP
GE JQ
HOLLEYGUTHRIE E
HOGANSON DK
COMSTOCK KE
OLSEN JC
KENNEY S
Citation: Rp. Rogers et al., KILLING EPSTEIN-BARR VIRUS-POSITIVE B-LYMPHOCYTES BY GENE-THERAPY - COMPARING THE EFFICACY OF CYTOSINE DEAMINASE AND HERPES-SIMPLEX VIRUS THYMIDINE KINASE, Human gene therapy, 7(18), 1996, pp. 2235-2245